newsfilter
← Latest News
GlobeNewswire·

KemPharm Announces Board and Leadership Changes to Support its Transformation into a Leading Rare Disease Company

Matthew R. Plooster named Chairman of the Board of DirectorsRichard W. Pascoe appointed Chief Executive OfficerTravis C. Mickle, Ph.D. transitions to PresidentJoshua Schafer appointed Chief Commercial Officer and